IL4 and asthma: Therefore, we neutralized IL-4 the main asthma-promoting T cell-derived cytokine by injecting three doses of an anti-IL-4 antibody (aIL-4), each time one hour before the intranasal OVA challenge was performed (days 28–30, supplemental Fig. 2).